Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 2/2008

01-04-2008 | Case Report

Successful treatment of new onset Wegener’s granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report

Authors: Seo Young Kim, Julie M. Linton, Sharon L. Kolasinski

Published in: Modern Rheumatology | Issue 2/2008

Login to get access

Abstract

We describe a patient with limited Wegener’s granulomatosis (WG) presenting during pregnancy with aggressive cutaneous involvement. She was treated with a combination of high-dose corticosteroids and intravenous immunoglobulin (IVIG) during her third trimester. The patient had otherwise uneventful pregnancy and a satisfactory outcome for both herself and her newborn. In the English literature, prior to this report, there have been de novo cases of WG in pregnant women that were diagnosed and treated during pregnancy and three cases of WG treated successfully with IVIG during pregnancy.
Literature
1.
Bellisai F, Morozzi G, Marcolongo R, Galeazzi M. Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin. Clin Rheumatol. 2004;23:533–5.PubMedCrossRef
2.
Talbot S, Main D, Levinson A. Wegener's granlomatosis: First report of a case with onset during pregnancy. Arthritis Rheum. 1984;27(1):109–11.PubMedCrossRef
3.
Palit J, Clague R. Wegener's granulomatosis presenting during first trimester of pregnancy. Br J Rheumatol. 1990;29:389–90.PubMedCrossRef
4.
Fields C, Ossorio M, Roy T, Bunke C. Wegener's granulomatosis complicated by pregnancy. J Reprod Med. 1991;36(6):463–6.PubMed
5.
Habib A, MacKay K, Abrons H. Wegener's granulomatosis complicating pregnancy: Presentation of two patients and review of the literature. Clin Nephrol. 1996;46(5):332–6.PubMed
6.
Luisiri P, Lance N, Curran J. Wegener’s granulomatosis in pregnancy. Arthritis rheum. 1997;40(7):1354–60.PubMed
7.
Dayoan E, Dimen L, Boylen C. Successful treatment of Wegener’s granulomatosis during pregnancy: a case report and review of the medical literature. Chest. 1998;113(3):836–8.PubMedCrossRef
8.
Pauzner R, Mayan H, Hershko E, Alcalay M, Farfel Z. Exacerbation of Wegener's granulomatosis during pregnancy: report of a case with tracheal stenosis and literature review. J Rheumatol. 1994;21:1153–6.PubMed
9.
Rossi F, Jayne D, Lockwood C, Kazatchkine M. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol. 1991;83:298–303.PubMedCrossRef
10.
Jayne D, Chapel H, Adu D et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM. 2000;93(7):433–9.PubMedCrossRef
11.
Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Expert Opin Investig Drugs. 2001;10(7):1279–89.PubMedCrossRef
12.
Mouthon L. Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins. Rev Med Interne. 1999;20(Suppl 4):431s–5s.PubMedCrossRef
13.
Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol. 1999;119(3):231–8.PubMedCrossRef
14.
Jayne D, Davies M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet. 1991;337(8750):1137–9.PubMedCrossRef
15.
Jayne D, Lockwood C. Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol. 1996;35(11):1150–3.PubMedCrossRef
16.
Richter C, Schnabel A, Csernok E, Reinhold-Keller E, Gross W. Treatment of Wegener's granulomatosis with intravenous immunoglobulin. Adv Exp Med Biol. 1993;336:487–9.PubMed
17.
Clark A. Clinical uses of intravenous immunoglobulin in pregnancy. Clin Obstet Gynecol. 1999;42(2):368–80.PubMedCrossRef
18.
Harber M, Tso A, Taheri S, Tuck S, Burns A. Wegener's granulomatosis in pregnancy—the therapeutic dilemma. Nephrol Dial Transplant. 1999;14(7):1789–91.PubMedCrossRef
19.
Masterson R, Pellicano R, Bleasel K, McMahon L. Wegener’s granulomatosis in pregnancy: a novel approach to management. Am J Kidney Dis. 2004;44(4):e68–72.PubMedCrossRef
Metadata
Title
Successful treatment of new onset Wegener’s granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report
Authors
Seo Young Kim
Julie M. Linton
Sharon L. Kolasinski
Publication date
01-04-2008
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 2/2008
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-008-0020-9

Other articles of this Issue 2/2008

Modern Rheumatology 2/2008 Go to the issue

Original Article

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)

Case Report

A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate

Original Article

Life expectancies of Japanese patients with rheumatoid arthritis: a review of deaths over a 20-year period

Original Article

In vivo change of elastic property in polyethylene acetabular components

Review Article

Hughes syndrome (the antiphospholipid syndrome): 25 years old

Case Report

A case of periodic-fever-syndrome-like disorder with lipodystrophy, myositis, and autoimmune abnormalities
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits